We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 1,353 results
  1. Imaging the effect of ketamine on synaptic density (SV2A) in the living brain

    The discovery of ketamine as a rapid and robust antidepressant marks the beginning of a new era in the treatment of psychiatric disorders. Ketamine...

    Sophie E. Holmes, Sjoerd J. Finnema, ... Irina Esterlis in Molecular Psychiatry
    Article 15 February 2022
  2. Deep phenoty** towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort

    Background

    Major Depressive Disorder (MDD) is a heterogenous brain disorder, with potentially multiple psychosocial and biological disease mechanisms....

    Kristian Høj Reveles Jensen, Vibeke H. Dam, ... Martin Balslev Jørgensen in BMC Psychiatry
    Article Open access 09 March 2023
  3. Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET)

    Purpose

    Exploring synaptic density changes during brain growth is crucial to understanding brain development. Previous studies in nonhuman primates...

    Samantha Rossano, Takuya Toyonaga, ... Richard E. Carson in European Journal of Nuclear Medicine and Molecular Imaging
    Article 28 May 2022
  4. Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A

    Purpose

    Synaptic abnormalities are associated with many brain disorders. Recently, we developed a novel synaptic vesicle glycoprotein 2A (SV2A)...

    Songye Li, Mika Naganawa, ... Yiyun Huang in European Journal of Nuclear Medicine and Molecular Imaging
    Article 08 January 2021
  5. Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder

    Cannabis is one of the most commonly and widely used psychoactive drugs. The rates of cannabis misuse have been increasing. Therefore, understanding...

    Deepak Cyril D’Souza, Rajiv Radhakrishnan, ... Patrick Skosnik in Molecular Psychiatry
    Article 24 September 2020
  6. Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue

    Purpose

    A [ 11 C]UCB-J blocking study was performed in healthy volunteers to validate simplified, non-invasive measures for quantifying presynaptic...

    Michel Koole, June van Aalst, ... Koen Van Laere in European Journal of Nuclear Medicine and Molecular Imaging
    Article 18 August 2018
  7. Lower synaptic density is associated with psychiatric and cognitive alterations in obesity

    Obesity is a serious medical condition that often co-occurs with stress-related psychiatric disorders. It is recognized that the brain plays a key...

    Ruth H. Asch, Sophie E. Holmes, ... Irina Esterlis in Neuropsychopharmacology
    Article 22 July 2021
  8. Evaluation of [11C]UCB-A positron emission tomography in human brains

    Background

    In preclinical studies, the positron emission tomography (PET) imaging with [ 11 C]UCB-A provided promising results for imaging synaptic...

    Mengfei **ong, Mark Lubberink, ... Gunnar Antoni in EJNMMI Research
    Article Open access 17 June 2024
  9. A systematic review and meta-analysis of neuroimaging studies examining synaptic density in individuals with psychotic spectrum disorders

    Background

    Psychotic disorders have long been considered neurodevelopmental disorders where excessive synaptic pruning and cortical volume loss are...

    Muhammad Omair Husain, Brett Jones, ... George Foussias in BMC Psychiatry
    Article Open access 19 June 2024
  10. Multiply restimulated human cord blood-derived Tregs maintain stabilized phenotype and suppressive function and predict their therapeutic effects on autoimmune diabetes

    Background

    Regulatory T cells (Tregs) are involved in the maintenance of immune homeostasis and immune regulation. Clinical trials on the adoptive...

    Yuanjie Bi, Ran Kong, ... Zhiguang Zhou in Diabetology & Metabolic Syndrome
    Article Open access 21 March 2024
  11. In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology - study protocol

    Background

    18 F-FDG brain PET is clinically used for differential diagnosis in cognitive dysfunction of unclear etiology and for exclusion of a...

    Greet Vanderlinden, Charles Carron, ... Koen Van Laere in BMC Medical Imaging
    Article Open access 12 February 2024
  12. Clinical significance of blocking novel immune checkpoint B7-H4 in urothelial carcinoma of bladder as a potential therapeutic target

    Urothelial Carcinoma of Bladder is complex disease with high mortality and recurrence rates. Current standard regimes have exhibited anti-tumor...

    David Raja, Aishwarya Singh, ... Prabhjot Singh in Medical Oncology
    Article 20 February 2024
  13. The Leuven late life depression (L3D) study: PET-MRI biomarkers of pathological brain ageing in late-life depression: study protocol

    Background

    Major depressive disorders rank in the top ten causes of ill health in all but four countries worldwide and are the leading cause of years...

    Louise Emsell, Maarten Laroy, ... Mathieu Vandenbulcke in BMC Psychiatry
    Article Open access 28 January 2021
  14. The neurobiology of duration of untreated psychosis: a comprehensive review

    Duration of untreated psychosis (DUP) is defined as the time from the onset of psychotic symptoms until the first treatment. Studies have shown that...

    Anthony W. Zoghbi, Jeffrey A. Lieberman, Ragy R. Girgis in Molecular Psychiatry
    Article 05 August 2022
  15. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A–Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity

    Purpose

    Current synaptic vesicle 2A (SV2A) positron emission tomography (PET) imaging agents include the nanomolar affinity probes [ 11 C]UCB-J and [ 18 F...

    Shil Patel, Ashley Knight, ... Jan Passchier in Molecular Imaging and Biology
    Article 14 November 2019
  16. The synaptic hypothesis of schizophrenia version III: a master mechanism

    The synaptic hypothesis of schizophrenia has been highly influential. However, new approaches mean there has been a step-change in the evidence...

    Oliver D. Howes, Ellis Chika Onwordi in Molecular Psychiatry
    Article Open access 11 April 2023
  17. News-Screen Rheumatologie

    Article 09 August 2023
  18. Differences among Indian and European pemphigus patients based on demographics, clinical parameters and propensity for relapse: results of a prospective bicontinental cohort study

    Background

    Limited studies have explored pemphigus variations among different ethnic groups residing in their respective geographical locations.

    ...
    Dipankar De, Shilpa Shilpa, ... Aikaterini Patsatsi in European Journal of Dermatology
    Article 01 November 2023
Did you find what you were looking for? Share feedback.